Microviable Therapeutics, a biotechnology company dedicated to the development of new biotherapeutic products based on intestinal microbiota and established in the Gijón Scientific and Technological Park, has been chosen by the Association of Scientific and [...]
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and Pilar Manrique, PhD, Research Scientist, will be attending the 8th Microbiome Movement - Drug Development Summit Europe which will take place from 30 January to 1 February 2024 [...]
From Microviable we want to express our most sincere wishes for you and your loved ones this holiday season. May this Christmas your days be filled with laughter, your home with love and your heart [...]
The microbiota plays a crucial role in human health, directly influencing digestive functions, protection against pathogens, modulation of the immune system, and the production of essential vitamins and metabolites. In relation to oncological processes, numerous [...]
Clarivate a research organization and global expert in data insights and collection, recognizes the true pioneers in their fields over the last decade, demonstrated by the production of multiple highly-cited papers that rank in the [...]
Microviable Therapeutics will participate in Microbiome Connect USA that will take place from November 14th to 16th in Boston. Claudio Hidalgo Cantabrana, CEO at Microviable, will join a like-minded community of 300 scientists and entrepreneurs [...]
The vast majority of microbiome studies failed to address core methodological aspects including the use of anaerobic conditions, sample volume, storage etc. with a lack of protocol normalization and standardization (1). Following the agreement [...]
During 2023 Microviable Therapeutics has attended several leading events in the fields of microbiota, pharma and investment. In some cases we have participated as speakers with presentations and posters. This is the case of Microbiome [...]
The experts’ committee of the Princess of Asturias awards has decided to grant this year´s award for technical and scientific research to Jeffrey Gordon, Bonnie L. Bassler and E. Peter Greenberg, experts and pioneers in [...]
Last Tuesday, Microviable Therapeutics attended the talks of Bonnie L. Bassler and Peter Greenberg, 2023 Princess of Asturias of Scientific and Technical research awards. Both explained their work on the phenomenon of quorum sensing, the [...]